Search clinical trials for: AZD3839 Placebo

Total 54016 results

Cocrystal Pharma, Inc.

Completed

A Study of CDI-31244: A Novel NNI in HV and HCV Infected Subjects

Hepatitis C

Canada
Galapagos NV

Completed

A Study to Evaluate the Effects of a Single and Multiple Oral Doses of GLPG3121 in Adult, Healthy, Male Subjects

Healthy

Belgium
Daewoong Pharmaceutical Co. LTD.

Completed

Efficacy and Safety of DWJ1252 in the Treatment of Functional Dyspepsia (PART 2)

Functional Dyspepsia

Korea, Republic of
GlaxoSmithKline

Completed

GR270773 In The Treatment Of Suspected Or Confirmed Gram-Negative Severe Sepsis In Adults

Sepsis

United States, Canada, France, Netherlands, Russian Federation, Taiwan, Czechia, Estonia, Spain, Sweden, Thailand, Germany, Belgium, Israel, United Kingdom, Korea, Republic of, Portugal, Finland, Latvia, New Zealand, Malaysia, South... and more
University of California, Davis

Completed

Effects of Cognitive Training on Academic Task Performance in Attention Deficit Hyperactivity Disorder (ADHD) (Cog-RAST)

ADHD | Attention

United States
Hong Kong Baptist University
Food and Health Bureau, Hong Kong; PuraPharm International (H.K.) Ltd

Completed

An Effectiveness and Safety Study of Chinese Herbal Medicine for Functional Constipation

Constipation | Functional Gastrointestinal Disorders

China
Soroka University Medical Center

Completed

Effect of Probiotics in Childhood Abdominal Pain

Abdominal Pain

Israel
Boehringer Ingelheim

Terminated

Comparison of Safety and Efficacy of COMBIVENT HFA to COMBIVENT (CFC) in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive
Akesobio Australia Pty Ltd

Completed

A Study of AK120 (IL-4Rα) in Healthy Subjects and Subjects With Moderate- to- Severe Atopic Dermatitis

Atopic Dermatitis

New Zealand, Australia
Ache Laboratorios Farmaceuticos S.A.

Terminated

Study to Assess Tolerability, Safety and Pharmacokinetics of a New Drug (ACH15)

Healthy

Brazil
CONRAD

Completed

Development of Adherence Biomarkers for Multiple Microbicide and Multipurpose Prevention Technology (MPT) Dosage Forms

HIV

United States
Woman's
Novo Nordisk A/S

Recruiting

Treatment to Regress to Normoglycemia in Women With a Recent History of GDM (SWEET)

Pre Diabetes | Postpartum Disorder

United States
Novartis Pharmaceuticals

Recruiting

Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V

Lupus Nephritis

France, Spain, Israel, Turkey, United States, Germany, India, Hungary, Malaysia, Portugal, Brazil, China, Puerto Rico, Hong Kong, Mexico, Singapore
Microbicide Trials Network
National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy... and other collaborators

Completed

Rectal Microbicide Acceptability, Tolerability and Adherence

HIV Prevention

United States, Malawi, Peru, South Africa, Thailand
Guangdong Zhongsheng Pharmaceutical Co., Ltd.

Completed

The Safety, Tolerability and Pharmacokinetic Study of ZSP1273 in Healthy Volunteers.

Influenza

China
Alebund Pty Ltd

Completed

A Safety, Tolerability, and Pharmacokinetics Study of AP303 in Healthy Subjects

Healthy Subjects

Australia
University of Sao Paulo General Hospital

Completed

Association Between tDCS and Lokomat Training in Patients With Incomplete Spinal Cord Injury

Spinal Cord Injuries

Brazil
Haisco Pharmaceutical Group Co., Ltd.

Completed

Safety, Tolerability and Pharmacokinetics of FTP-198 Tablet in Healthy Chinese Volunteers (FTP-198)

Healthy

China
Philipps University Marburg Medical Center

Completed

Longterm Effects of Expectations on Mood

Healthy Participants

Germany
Massachusetts General Hospital
National Institutes of Health (NIH); National Center for Complementary and...

Completed

Molecular and Functional PET-fMRI Measures of Analgesia in Migraine

Healthy | Migraine

United States
University of Haifa

Unknown

Experimental Pain Reporting Accuracy and Placebo Response

Pain | Healthy | Placebo Effect

Israel
Dana-Farber Cancer Institute

Terminated

Harnessing the Effect of an Open-Label Placebo on Fatigue in Cancer Survivors

Fatigue in Cancer Survivors

United States
UMC Utrecht
Erasmus Medical Center; Academisch Medisch Centrum - Universiteit van Amsterdam... and other collaborators

Unknown

Effects of Evolocumab Versus Placebo Added to Standard Lipid-lowering Therapy on Fasting and Post Fat Load Lipids in Patients With Familial Dysbetalipoproteinemia (EVOLVE-FD)

Hyperlipoproteinemia Type III | Familial Dysbetalipoproteinemia
University of Rochester

Recruiting

Efficacy of IV Acetaminophen Versus Oral Acetaminophen

Nephrectomy

United States
Infinity Pharmaceuticals, Inc.
Bristol-Myers Squibb

Completed

Study to Evaluate the Efficacy/Safety of IPI-549 in Combination With Nivolumab in Patients With Advanced Urothelial Carcinoma (MARIO-275)

Solid Tumor | Bladder Cancer | Advanced Cancer | Urothelial Carcinoma

France, Spain, United States, Italy, Czechia, Poland, Serbia
Kyunghee University Medical Center

Completed

Effect of Herbal Extract Granules Combined With Probiotics on Irritable Bowel Syndrome With Diarrhea

Irritable Bowel Syndrome

Korea, Republic of
Ji Xing Pharmaceuticals Australia Pty Ltd
Novotech (Australia) Pty Limited

Recruiting

JX09 SAD/MAD in Healthy Participants

Resistant Hypertension

Australia
Brigham and Women's Hospital
Boston Medical Center

Recruiting

NAD Augmentation in Diabetes Kidney Disease (DKD)

Diabetic Kidney Disease | Type2diabetes

United States
Tasly Pharmaceutical Group Co., Ltd

Recruiting

HuHuangLianzonggan Capsule in Subjects With Nonalcoholic Steatohepatitis: a Phase 2 tRial(HHL-HEPAR)

NASH

China
Shanghai Jiao Tong University School of Medicine
Shanghai Chest Hospital

Recruiting

Limonene for Pulmonary Nodule Chemoprevention

Pulmonary Nodules

China
Suzhou Kintor Pharmaceutical Inc,

Terminated

A Study to Evaluate the Efficacy and Safety of Proxalutamide (GT0918) in Hospitalized COVID-19 Subjects

Covid19

United States, China, Philippines, South Africa, Ukraine
Alexion Pharmaceuticals

Completed

Study of Subcutaneous and Intravenous ALXN1720 With and Without rHuPH20 in Healthy Subjects

Healthy

United Kingdom
University of Helsinki
Tampere University

Completed

Effect of Modified Playground Environment on Health, Particularly Immune System (ImmunoG1)

Immune System Diseases | Atopic Disorders

Finland
Eli Lilly and Company

Completed

A Study of LY2127399 in Participants With Systemic Lupus Erythematosus

Systemic Lupus Erythematosus | Autoimmune Disease | Connective Tissue Disease

India, United States, Hungary, Romania, Spain, France, Taiwan, Russian Federation, United Kingdom, Australia, Latvia, Mexico, South Africa, Canada, Israel, Brazil, Serbia, Ecuador, Malaysia, New Zealand, Tunisia
Abbott
Datamap; Linical Co., Ltd.

Completed

A Study Investigating the Immunologic Effects and Safety of 60-day Treatment of the ALK HDM Tablets in Adult Subjects With HDM-Induced Allergic Rhinitis and/or Atopic Asthma

Asthma | Allergy | Rhinitis

Belarus, Russian Federation
Yooyoung Pharmaceutical Co., Ltd.

Completed

Clinical Trial of YYD302 for Treatment of Osteoarthritis of the Knee

Osteoarthritis, Knee

Korea, Republic of
Pfizer

Completed

Evaluation Of Safety, Tolerability And Pharmacokinetics Of Single And Multiple Doses Of Compound PF-06823859

Healthy

United States
Novaremed Ltd.

Completed

Effect of NRD135S.E1 in Peripheral Neuropathic Pain in Diabetic Patients

Diabetic Peripheral Neuropathic Pain

Israel
Medical University Innsbruck

Completed

Fibrinogen Concentrate (FGTW) in Trauma Patients, Presumed to Bleed (FI in TIC)

Trauma | Massive Hemorrhage

Austria, Czech Republic, Germany
Bionorica SE

Completed

Efficacy and Safety of a Herbal Medicinal Product (Dry Extract BNO 1016) in Patients With Acute Rhinosinusitis

Acute Rhinosinusitis

Germany
Klinikum der Universitaet Muenchen, Grosshadern

Completed

Efficacy of Local Overpressure Treatment for Meniere's Disease

Meniere's Disease

Germany
Lawson Health Research Institute
London Health Sciences Centre; St. Joseph's Health Care London; The W. Garfield...

Recruiting

Prebiotic Therapy to Improve Outcomes of Renal Transplant

Kidney Transplant; Complications

Canada
Novartis Pharmaceuticals

Active, not recruiting

A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Rate of Weekly Lipoprotein Apheresis Sessions in Patients With Hyperlipoproteinemia(a) and Established Cardiovascular Disease in Germany

Hyperlipoproteinemia(a)

Germany
Ono Pharmaceutical Co. Ltd

Completed

Single Ascending Dose Study to Assess the Safety, Tolerability, PK and PD of ONO-4685 in Japanese and Caucasian Healthy Adult Male Subjects

Healthy Volunteers

Japan
AJU Pharm Co., Ltd.

Completed

Efficacy and Safety of AJU-A51 in Type 2 Diabetes Mellitus Patients

Type2 Diabetes

Korea, Republic of
Sir Mortimer B. Davis - Jewish General Hospital

Active, not recruiting

The MUFFIN-PTS Trial (MUFFIN-PTS)

Post-Thrombotic Syndrome

Canada
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Completed

A Study of HS-10353 in Chinese Participants.

Major Depressive Disorder

China
Enzychem Lifesciences Corporation

Completed

EC-18 for Oral Mucositis in Patients With Concomitant Chemoirradiation

Stomatitis

United States
AstraZeneca

Completed

A Study to Evaluate the Safety and Tolerability of AZD7442 in Chinese Adults

Coronavirus Disease 2019 (COVID-19)

China
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Completed

A Study To Evaluate The Safety, Tolerability And Pharmacokinetics of HS-10345 In Treatment-Resistant Depression

Treatment Resistant Depressive Disorder

China

Search clinical trials for: AZD3839 Placebo

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ghana

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations